Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 122, Issue 2, Pages 419-428
Publisher
Springer Nature
Online
2010-05-17
DOI
10.1007/s10549-010-0928-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profiles
- (2010) Robert R Kitchen et al. BMC GENOMICS
- Phospho-p70S6K/p85S6K and cdc2/cdk1 Are Novel Targets for Diffuse Large B-Cell Lymphoma Combination Therapy
- (2009) M. Y. Zhao et al. CLINICAL CANCER RESEARCH
- Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to Letrozole
- (2009) William R. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women
- (2008) J. Murray et al. BREAST CANCER RESEARCH AND TREATMENT
- The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
- (2008) Robin L. Jones et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of mTOR in the management of solid tumors: An overview
- (2008) Alex S. Strimpakos et al. CANCER TREATMENT REVIEWS
- Targeted therapies in breast cancer: Where are we now?
- (2008) Serena Di Cosimo et al. EUROPEAN JOURNAL OF CANCER
- Clinical Application of the 70-Gene Profile: The MINDACT Trial
- (2008) Fatima Cardoso et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors
- (2008) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors
- (2008) Anne O'Donnell et al. JOURNAL OF CLINICAL ONCOLOGY
- Systems-Level Analysis of ErbB4 Signaling in Breast Cancer: A Laboratory to Clinical Perspective
- (2008) C.-P. Chuu et al. MOLECULAR CANCER RESEARCH
- Predicting response and resistance to endocrine therapy
- (2007) William R. Miller et al. CANCER
- The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics
- (2007) Ahmad Awada et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started